KEROS THERAPEUTICS INC's ticker is KROS and the CUSIP is 492327101. A total of 112 filers reported holding KEROS THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $967,454 | -10.9% | 22,657 | +0.2% | 0.13% | -25.6% |
| Q4 2022 | $1,085,300 | +27.2% | 22,601 | -0.3% | 0.18% | +36.4% |
| Q3 2022 | $853,000 | -35.1% | 22,663 | -52.3% | 0.13% | +11.2% |
| Q2 2022 | $1,314,000 | +40.8% | 47,546 | +177.2% | 0.12% | +45.0% |
| Q1 2022 | $933,000 | +290.4% | 17,155 | +342.6% | 0.08% | +370.6% |
| Q1 2021 | $239,000 | – | 3,876 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 407,633 | $12,995,340 | 5.15% |
| Opaleye Management Inc. | 360,400 | $11,489,552 | 3.74% |
| Parkman Healthcare Partners LLC | 298,475 | $9,515,383 | 1.74% |
| BRAIDWELL LP | 1,357,309 | $43,271,011 | 1.37% |
| First Light Asset Management, LLC | 421,438 | $13,435,443 | 1.28% |
| Orbimed Advisors | 1,514,734 | $48,289,720 | 1.03% |
| Yiheng Capital Management, L.P. | 554,151 | $17,666,334 | 0.90% |
| Nantahala Capital Management | 328,781 | $10,481,538 | 0.90% |
| DAFNA Capital Management LLC | 65,961 | $2,102,837 | 0.65% |
| EDBI Pte Ltd | 10,105 | $322,147 | 0.35% |